help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2008-1757
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Dasu, M. R.
Right arrow Articles by Jialal, I.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dasu, M. R.
Right arrow Articles by Jialal, I.
Endocrinology Vol. 150, No. 8 3457-3464
Copyright © 2009 by The Endocrine Society

Pioglitazone Inhibits Toll-Like Receptor Expression and Activity in Human Monocytes and db/db Mice

Mohan R. Dasu, Samuel Park, Sridevi Devaraj and Ishwarlal Jialal

Laboratory for Atherosclerosis and Metabolic Research (M.R.D., S.P., S.D., I.J.), University of California, Davis Medical Center, Sacramento California 95817; and Veterans Affairs Medical Center (I.J.), Sacramento, California 95655

Address all correspondence and requests for reprints to: Mohan R. Dasu, Ph.D., Laboratory for Atherosclerosis and Metabolic Research, University of California, Davis, Medical Center, 4635, 2nd Avenue, Research Building 1, Sacramento, California 95817. E-mail: ravi.dasu{at}ucdmc.ucdavis.edu.

Toll-like receptors (TLRs) are key innate immune sensors of endogenous damage signals and play an important role in inflammatory diseases like diabetes and atherosclerosis. Pioglitazone (PIO), a peroxisome proliferator-activated receptor (PPAR)-{gamma} agonist, has been reported to be an antiinflammatory agent. Thus, in the present study, we examined the antiinflammatory effects of PIO on TLR2 and TLR4 expression in human monocytes exposed to Pam3CSK4 (Pam; TLR2 ligand) and purified lipopolysaccharide (LPS; TLR4 ligand) using flow cytometry and real-time RT-PCR. Monocytes were isolated from healthy human volunteers and pretreated with PIO (1 µM) followed by Pam (170 ng/ml) and LPS (160 ng/ml) challenge. PIO significantly decreased Pam- and LPS-induced TLR2 (–56%) and TLR4 (–78%) expression (P < 0.05). In addition, PIO decreased TLR ligand-induced nuclear factor-{kappa}B activity (–63%), IL-1β (–50%), IL-6 (–52%), monocyte chemoattractant protein-1(–83%), and TNF-{alpha} (–87%) compared with control. Next, PIO-treated db/db mice (n = 6/group) showed decreased TLR2 (–60%) and TLR4 (–45%) expression in peritoneal macrophages compared with vehicle control mice (P < 0.001) with associated decrease in MyD88-dependent signaling and nuclear factor-{kappa}B activation. Data suggest that Pam- and LPS-induced TLR2 and TLR4 expression are inhibited by PIO in human monocytes and db/db mice. Thus, we define a novel pathway by which PIO could induce antiinflammatory effects.




This article has been cited by other articles:


Home page
J. Nutr.Home page
C. M. Reynolds, E. Draper, B. Keogh, A. Rahman, A. P. Moloney, K. H. G. Mills, C. E. Loscher, and H. M. Roche
A Conjugated Linoleic Acid-Enriched Beef Diet Attenuates Lipopolysaccharide-Induced Inflammation in Mice in Part through PPAR{gamma}-Mediated Suppression of Toll-Like Receptor 4
J. Nutr., December 1, 2009; 139(12): 2351 - 2357.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society